Under the cold, clinical glow of his office lights, I received the call that set the next challenge into motion—a biotech firm couldn’t get another round of funding after the FDA approval failed, buried under a mountain of debt and regulatory scrutiny. The voice on the other end was Jerri, a friendly Venture Capitalist I’d...
As Dr. Doom, a Chief Restructuring Officer, I’ve faced many challenges, but the case of this chair company was particularly intriguing. The founder, an eccentric and brilliant architect, had combined his passion for design with the unparalleled craftsmanship of Amish artisans. Yet, his pursuit of perfection was leading the company to financial peril. It was...
